SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Teslas next-generation Roadster reveal, featuring SpaceX-developed thrusters, is driving attention, alongside speculation that the showcase signals closer Tesla-SpaceX ties or a potential merger. Traders are split between praising the engineering and questioning the cars practicality, regulatory prospects, and near-term earnings impact.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

The iPhone Duos rapid preorder sellout is driving attention, with traders debating whether it signals strong demand or simply reflects limited inventory and manufacturing constraints. The news has fueled bullish momentum, while skeptics point to Apples high valuation and repeated price fades.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

Concerns about CoreWeaves heavy borrowing to fund AI data-center expansion and stressed bonds are driving the debate, with traders questioning whether future demand and cash flow can support its financing needs. The selloff has prompted bargain-buying and optimism around Nvidia CEO Jensen Huangs reassurance and bullish analyst views, while skeptics point to debt risk and insider share sales.

Zeta Global Holdings Corp. operates as a marketing technology software company, which engages in the provision of enterprises with consumer intelligence and marketing automation software. It enables its customers to target, connect and engage consumers through software that delivers marketing across all addressable channels, including email, social media, web chat, connected TV and video among others. The company was founded by David A. Steinberg and John Sculley on May 9, 2012 and is headquartered in New York, NY.

Zeta Global Holdings Corp - Ordinary Shares - Class A

Zeta Global Holdings Corp

Analyst upgrades and Zeta Live announcementsincluding the AthenaOS launch and AI/enterprise partnershipsare driving attention as Zetas marketing platform is framed as a beneficiary of growing enterprise AI adoption. Bulls point to the upgrades and product momentum, while skeptics warn the rally may be extended and debate whether to take profits or wait for a pullback.

Omeros Corp. operates as a biopharmaceutical company, which engages in the research, discovery, development, and commercialization of small-molecule and protein therapeutics targeting immunologic diseases. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

European regulators reaffirmed their refusal of Omeros narsoplimab application after re-examination, weighing on shares. Traders are debating the review processOmeros says its submitted patient-level data were not shared with the expert groupwhile some see U.S. approval and Yartemlea demand as a counterweight to the European setback.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS shares are drawing attention amid a sharp decline and an extended quiet period as traders await the final analysis of the Phase 3 REGAL AML trial and updates on its 80th-event milestone; some expect data around the ASH conference, while others worry the delay signals trouble. The selloff is widely blamed by traders on options expiration, short selling, or manipulation, though those explanations are speculative, and reactions range from buying the dip to frustration over the lack of company updates.

Regencell Bioscience Holdings Ltd. is a early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder. The company was founded by Yat-Gai Au on October 30, 2014 and is headquartered in Hong Kong.

Regencell Bioscience Holdings Ltd

Traders are speculating that RGC could repeat a past meme-stock surge, pointing to the CEOs large ownership stake, limited trading supply and reportedly high borrowing costs as potential short-squeeze conditions. Others counter that the moves are hype-driven and warn of thin liquidity, sharp reversals and no clear new catalyst.

PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.

PayPal Holdings Inc

Renewed takeover speculation is dominating discussion: traders are circulating a report that an unnamed West Coast tech company may be considering an all-stock acquisition, with many guessing Meta, but no offer is confirmed. Some see the rumor as potential upside, while others dismiss it as another short-lived pump; PayPals Meta Muse checkout partnership is also cited as strategic context.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

Concerns about Pharvaris competing HAE treatment and its potential to pressure Orladeyos growth are weighing on sentiment, alongside reported RBC caution about BioCrysts near-term outlook. Some traders view the selloff as overdone and argue Orladeyo can retain patients while the market awaits further pipeline data.

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. It operates through the Steelmaking and Other Businesses segments. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

Elevated hot-rolled steel prices and contract resets have fueled optimism around Cleveland-Cliffs earnings outlook, with traders anticipating improved profitability and debt reduction. Others remain skeptical, pointing to the companys heavy debt, past losses and Stelco-related risks.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Seeking Clues to Home Bancorp (HBCP) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics

Besides Wall Street's top-and-bottom-line estimates for Home Bancorp (HBCP), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2026.

Home Bancorp Reports Q2 2026 Results: Full Earnings Call Transcript

On Tuesday, Home Bancorp (NASDAQ:HBCP) discussed second-quarter financial results during its earnings call. The full transcript is provided below.
Benzinga APIs provide real-time access to earnings call transcripts andread more...

Home Bancorp (HBCP) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Although the revenue and EPS for Home Bancorp (HBCP) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Home Bancorp (HBCP) Beats Q2 Earnings and Revenue Estimates

Home Bancorp (HBCP) delivered earnings and revenue surprises of +1.37% and +2.82%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

HOME BANCORP, INC. ANNOUNCES 2026 SECOND QUARTER RESULTS AND INCREASES QUARTERLY DIVIDEND BY 3%

HOME BANCORP, INC. ANNOUNCES 2026 SECOND QUARTER RESULTS AND INCREASES QUARTERLY DIVIDEND BY 3% HOME BANCORP, INC. ANNOUNCES 2026 SECOND QUARTER RESULTS AND INCREASES QUARTERLY DIVIDEND BY 3% PR Newswire LAFAYETTE, La., July 20, 2026 LAFAYETTE, La., July 20, 2026 /PRNewswire/ -- Home Bancorp, Inc...

Curious about Home Bancorp (HBCP) Q2 Performance? Explore Wall Street Estimates for Key Metrics

Beyond analysts' top-and-bottom-line estimates for Home Bancorp (HBCP), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2026.

HOME BANCORP, INC. TO ISSUE 2026 SECOND QUARTER EARNINGS AND HOST CONFERENCE CALL

HOME BANCORP, INC. TO ISSUE 2026 SECOND QUARTER EARNINGS AND HOST CONFERENCE CALL HOME BANCORP, INC. TO ISSUE 2026 SECOND QUARTER EARNINGS AND HOST CONFERENCE CALL PR Newswire LAFAYETTE, La., July 2, 2026 LAFAYETTE, La., July 2, 2026 /PRNewswire/ -- Home Bancorp, Inc. (Nasdaq:HBCP) (the "Company...

Catalyst Climbs 33% in a Year: Should You Buy the Stock?

CLST is poised for growth, supported by a transformational acquisition, healthy liquidity, improving credit trends and an expanding commercial banking footprint.

Home Bancorp (HBCP) Upgraded to Buy: Here's What You Should Know

Home Bancorp (HBCP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Darren Guidry Sells 1,600 Shares of Home Bancorp (NASDAQ:HBCP) Stock

Home Bancorp, Inc. (NASDAQ:HBCP - Get Free Report) EVP Darren Guidry sold 1,600 shares of the stock in a transaction on Wednesday, April 29th. The stock was sold at an average price of $62.78, for a...

Home Bancorp, Inc. is a holding company, which engages in providing commercial banking services through its subsidiaries. It offers deposit and loan products through banking centers in South Louisiana and Western Mississippi. The company was founded in 1908 and is headquartered in Lafayette, LA.

Home Bancorp Inc

Neutral Sentiment

50bps hike

25bps hike

No change

Rate cut

September CPI rose 0.6% from the prior month to 3.7% annually, while producer prices jumped 6.3% year-over-year, the biggest gain since 2022, putting the Federal Reserve's October 27-28 meeting squarely in focus after its first rate hike in three years last month. What does the Fed do at its October meeting? Vote and explain your reasoning in the comments.

September CPI hit 3.7% and PPI jumped 6.3%, both hotter than expected. What does the Fed do at its October meeting?

Current Price	$66.73
Prev Close	$65.87
Open	$66.25
Dividend Yield	1.97%
50-Day Moving Average	$68.77
Beta	0.83
Avg. Volume	62,599.85
PE Ratio	11.01

52-Week High	$74.50
52-Week Low	$51.05
Market Capitalization	$518.45M
EPS (Annual)	$5.87
Price to Book	1.14
Revenue Per Employee	$428,298.35

Feed

News

Sentiment

Earnings

Fundamentals

Info

HBCP Fundamentals